Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy
Melissa Hines(St. Jude Children's Research Hospital), Aimee C. Talleur(St. Jude Children's Research Hospital), Yinmei Zhou(St. Jude Children's Research Hospital), Camille Keenan(University of Washington), Stephen Gottschalk(St. Jude Children's Research Hospital), Akshay Sharma(St. Jude Children's Research Hospital), Gabriela Marón(St. Jude Children's Research Hospital), Cheng Cheng(Jilin University), Brandon M. Triplett(St. Jude Children's Research Hospital), Caitlin Hurley(St. Jude Children's Research Hospital), Kim E. Nichols(St. Jude Children's Research Hospital)
Cited by 122
Related Papers
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
|The Lancet Oncology|2015|211
Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia
|Cancer Cell|2018|207
Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
|Nature Reviews Clinical Oncology|2018|184